Interleukin 17a Protein
Quick Overview for Interleukin 17a Protein (ABIN7199556)
Target
See all Interleukin 17a (IL17A) ProteinsProtein Type
Origin
Source
Purity
Grade
-
-
Purpose
- Human IL-17A / CTLA-8 Protein, Tag Free (MALS verified)
-
Sequence
- Gly 24 - Ala 155
-
Characteristics
- Human IL17A, Tag Free (ILA-H5219) is expressed from human 293 cells (HEK293). It contains AA Gly 24 - Ala 155 (Accession # Q16552-1).
-
Endotoxin Level
- Less than 1.0 EU per μg by the LAL method.
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Application Notes
- This protein carries no "tag". The protein has a calculated MW of 15.1 kDa. As a result of glycosylation, the protein migrates as 16 kDa, 17 kDa and 19 kDa under reducing (R) condition, and 27-34 kDa under non-reducing (NR) condition .
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Buffer
- PBS, pH 7.4
-
Storage
- -20 °C
-
Storage Comment
- -20°C
-
-
- Interleukin 17a (IL17A) (Interleukin 17A (IL17A))
-
Alternative Name
- IL-17A / CTLA-8
-
Background
-
Synonyms: IL-17A,Interleukin-17A,CTLA-8,IL-17,
Description: Interleukin-17A (IL17A) is also known as cytotoxic T-lymphocyte-associated antigen 8 (CTLA8),which is a proinflammatory cytokine produced by activated T cells. IL17A can regulate the activities of NF-kappaB and mitogen-activated protein kinases. Also,IL17A can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO).Furthermore,IL17A has been found both in glycosylated and nonglycosylated forms. High levels of IL-17 are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis. -
Molecular Weight
- 15.1 kDa
-
NCBI Accession
- NP_002181
Target
-